Marguerite Neerman-Arbez obtained her Ph.D. in Molecular Biology from the University of Geneva in 1994. During her post-doctoral training with Professor Stylianos Antonarakis, she became interested in the genetics of human bleeding disorders. In 2002, Dr. Neerman-Arbez was awarded a Career Development Professorship from the Swiss National Foundation. Since 2013 she is a Full Professor at the Department of Genetic Medicine and Development at the Faculty of Medicine, University of Geneva. Marguerite Neerman-Arbez has received several international scientific prizes including in 2018 the Outstanding Investigator Award from the International Fibrinogen Research Society. Her current research focusses on translating genetic information obtained from next generation sequencing into clinical benefits for patients with congenital fibrinogen disorders by studying properties of fibrin clots prepared from patient samples and modelling genetic variants in the zebrafish.